Blueweave
Point Of Care Infectious Disease Testing Market

Point Of Care Infectious Disease Testing Market

Point of Care (PoC) Infectious Disease Testing Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028, Segmented, By Technique (Agglutination Test, Flow-through Test/Immuno-Concentration Assay, Molecular Diagnostics), POC Testing Kits); By Disease (HIV PoC, Clostridium Difficile PoC, HBV PoC, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV) PoC, HPV PoC, Influenza/Flu PoC, HCV PoC, MRSA PoC, TB and Drug-Resistant TB PoC, HSV (Herpes Simplex Virus) PoC, Others); By End Use (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: September 2022
  • Report ID: BWC22371
  • Available Format: PDF
  • Page: 146

Report Overview

Increasing incidences of infectious diseases including HIV, influenza, RSV, and pandemics (Covid-19, etc.) and epidemics among people across the countries are expected to drive the huge demand for point-of-care testing kits.

Global Point of Care (PoC) Infectious Disease Testing Market - Overview

Pathogenic microorganisms, such as bacteria, parasites, viruses, and fungi, cause infectious diseases. It may transfer from one person to another directly or inadvertently. Some of the typical signs and symptoms of infectious diseases include fever, muscle aches, diarrhea, and weariness. To find the pathogenic bacteria, numerous laboratory tests, imaging scans, and biopsies are performed. By shortening the time between testing and infection diagnosis, PoC assays for infectious diseases can enhance the identification and management of infectious diseases. PoC testing are now the most effective and efficient method of providing healthcare due to new developments in healthcare, such as healthcare at home.

Global Point of Care (PoC) Infectious Disease Testing Market - Industry Trends & Market Forecast

The global market for PoC infectious disease diagnostics will realize its growth potential as a result of the miniaturization of PoC testing equipment. Some market trends include the standardization of PoC testing equipment and the acquisition of small businesses. Use of nanotechnology in the diagnosis of infectious diseases attracted significant investments. Despite the enormous efforts made to control infectious diseases, there remains a huge market for affordable, precise, and sensitive PoC solutions. The healthcare sector now has access to a wide range of applications thanks to nanotechnology. The development of PoC platforms based on nanoparticles and nanodevices has received emphasis from a number of players. A small number of samples in kits created using nanotechnology can be used to diagnose a condition and provide patients with results in real time. As a result, the use of nanotechnology in infectious illness diagnostics yields accurate and timely results.

Growth Drivers

Increasing Prevalence of Infectious and Chronic Diseases

Due to increased rates of chronic diseases and the rise of infectious diseases, the market for point of care diagnostics is anticipated to expand significantly throughout the forecast period. Additionally, the market is anticipated to be driven by the rising popularity of decentralized health systems. Additionally, it is expected that the market would grow during the forecast period due to the adoption of new breakthroughs and technical improvements in the industry by key market players. In the coming years, growth in the PoC diagnostics market is expected as a result of these factors.

Growing Preference for Decentralized Healthcare System

PoC diagnosis has grown to be an essential component of patient-centric healthcare, because of various benefits including rapid turnaround times and the opportunity to make treatment decisions right away. Improvements in patient care have resulted from a preference shift from centralized to decentralized PoC testing for infectious diseases. The industry is being driven by the market participants' willingness to offer PoC goods to remote places due to the rising need for quick examinations.

Restraints

Stringent Regulatory Requirements

PoC testing's shortcomings relative to central lab methods and onerous and time-consuming regulatory requirements are the main factors limiting the market's expansion. Accuracy problems at the PoC diagnostic procedures may affect the adoption rate. A majority of people worldwide who have infectious diseases including HIV, malaria, and tuberculosis live in underdeveloped countries. Lack of clinical expertise and difficult product accessibility brought on by lower per capita spending have resulted in a decline in the use of PoC kits in low- and middle-income countries. It leads to incorrect finding interpretations, which affects the test's accuracy. Consequently, it would impede the market expansion.

Segmental Coverage

Global Point of Care (PoC) Infectious Disease Testing Market - By Technique

Agglutination test, flow-through test/immuno-concentration assay, molecular diagnostics, and others are market segments based on the technique. The lateral flow immunoassay market segment held a major market share. The quicker diagnosis and accessibility of the test kits in decentralized settings are responsible for its leadership. The increasing use of innovations, such as RT-PCR and ELISA in infectious disease PoC testing kits is expected to drive the market by 2028. Additionally, the increase in FDA approvals is probably going to accelerate the segment's revenue growth. Due to the growing number of market participants working to introduce advanced kits based on the flow-through technique in the international market, the flow-through test/immunoconcentration assay segment is anticipated to expand at a significant CAGR during the forecast period.

Global Point of Care (PoC) Infectious Disease Testing Market - By Disease

HIV, hepatitis B virus, pneumonia/streptococcus related infections, respiratory syncytial virus, influenza, clostridium difficile infections (CDI), hepatitis C virus, MRSA, tuberculosis, and others are the different disease segments in the Global Point of Care (PoC) Infectious Disease Testing market by disease. The burden of underdiagnosis and the rising frequency of infectious diseases around the world have sped up the use of PoC testing kits and boosted industry growth. As influenza is the primary cause of acute respiratory infection, these diagnostic products are being used more frequently for effective illness management. Additionally, it is projected that the increased R&D investments for sophisticated PoC kits in emerging countries will accelerate the expansion of the influenza category.

Global Point of Care (PoC) Infectious Disease Testing Market - By End
User

Hospital bedside, doctor's office lab, urgent care & retail clinics, home & self-testing, nursing homes, and others are the end-user segments in the Global Point of Care (PoC) Infectious Disease Testing market. During the period in analysis, the hospital bedside segment is expected to hold a commanding market share. The rise in hospital stays by patients with infectious diseases is to blame for its domination. The need for infectious disease PoC diagnostics in hospital settings has ultimately increased as a result of this. By the end of the forecast period, the home & self-testing segment is expected to have grown significantly due to the rising preference shift of patients from hospital to home care diagnosis. The urgent care & clinics segment is expected to grow at a higher CAGR during the forecast period due to the increased number of stand-alone urgent care & clinics in developed and emerging countries.

Impact of COVID-19 on Global Point of Care (PoC) Infectious Disease Testing Market

Numerous sectors were impacted by the COVID-19 pandemic in terms of revenue and output. The pandemic has, however, had a favorable effect on the healthcare industry. Due to an increase of COVID-19 cases and a rise in the need for frequent tests, PoC diagnostics were in high demand. Major market firms have introduced innovative items in response to consumer demand during the pandemic. These elements supported the Global Point of Care (PoC) Infectious Disease Testing market expansion during the pandemic period.

Regional Insights

Due to an increase in infectious disease incidences and the frequency of chronic diseases among its population, North America currently holds a disproportionately large part of the global market for PoC diagnostics. Due to advantageous reimbursement policies that are predicted to increase service demand, the regional market growth is anticipated to continue during the period in analysis. The rising production of cutting-edge goods, Europe is forecast to hold the second-highest position in the global market during the projection period. Additionally, rising government R&D investments would fuel the regional market expansion. As more market participants are entering the region and PoC diagnostics kits are being used more frequently, the market in Asia Pacific (APAC) will grow at the fastest rate. Additionally, market participants in the APAC region are investing heavily, which will increase demand for cutting-edge goods. Due to a lack of knowledge about the advantages of PoC diagnostics among the healthcare community, Latin America and the Middle East and Africa made up a significantly smaller portion of the market.

Competitive Landscape

Thermo Fisher Scientific Inc., Alere Inc., Calypte Biomedical Corporation, Chembio Diagnostic Systems, Inc., Meridian Bioscience, Inc., MedMira, Inc., Trinity Biotech plc, Sekisui Diagnostics, OraSure Technologies, Inc., and Quidel Corporation are major players in the global PoC infectious disease diagnostics market.

Recent Developments

Chembio Diagnostics, Inc., released the quick PoC COVID-19/Flu A&B test in April 2021. Results of the test are available in 15 minutes. Roche launched the Cobas SARS-CoV-2 Variant Set 1 Test in March 2021. The test is designed to find COVID-19 variations that are present in the UK, South Africa, and Brazil.

 

Scope of the Report

Attributes  Details
Years Considered Historical Data – 2018–2021
Base Year – 2021
Estimated Year – 2022
Forecast – 2022–2028 
Facts Covered Revenues in USD Million
Market Coverage North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Product/Service Segmentation By Technique, By Disease, By End Use, By Region
Key Players Thermo Fisher Scientific Inc., Alere Inc., Calypte Biomedical Corporation, Chembio Diagnostic Systems, Inc., Meridian Bioscience, Inc., MedMira, Inc., Trinity Biotech plc, Sekisui Diagnostics, OraSure Technologies, Inc., and Quidel Corporation.

 

By Technique

  • Lateral Flow
  • Agglutination Assays
  • Flow-Through Test
  • Molecular Diagnostics
  • Others

By Disease

  • HIV POC
  • Clostridium difficile POC
  • HBV POC
  • Pneumonia or Streptococcus associated infections
  • Respiratory syncytial virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB and drug-resistant TB POC
  • HSV (Herpes Simplex Virus) POC
  • Others

By End Use

  • Hospitals
  • Clinics
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumption & Limitation
  3. Executive Summary
  4. Global Point Of Care Infectious Disease Testing Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
    3. Technological Advancement/Recent Development
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  5. Global Point Of Care Infectious Disease Testing Market Overview
    1. Market Size & Forecast by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
        1. Lateral Flow
        2. Agglutination Assays
        3. Flow-Through Test
        4. Molecular Diagnostics
        5. Others
      2. By Disease
        1. HIV POC
        2. Clostridium difficile POC
        3. HBV POC
        4. Pneumonia or Streptococcus associated infections
        5. Respiratory syncytial virus (RSV) POC
        6. HPV POC
        7. Influenza/Flu POC
        8. HCV POC
        9. MRSA POC
        10. TB and drug-resistant TB POC
        11. HSV (Herpes Simplex Virus) POC
        12. Others
      3. By End Use
        1. Hospitals
        2. Clinics
        3. Home
        4. Assisted Living Healthcare Facilities
        5. Laboratories
        6. Others
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific
        4. Latin America
        5. Middle East and Africa
  6. North America Point Of Care Infectious Disease Testing Market
    1. Market Size & Forecast by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Disease
      3. By End Use
      4. By Country
        1. United States
        2. Canada
  7. Europe Point Of Care Infectious Disease Testing Market
    1. Market Size & Forecast by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Disease
      3. By End Use
      4. By Country
        1. Germany
        2. United Kingdom
        3. Italy
        4. France
        5. Spain
        6. Rest of Europe
  8. Asia Pacific Point Of Care Infectious Disease Testing Market
    1. Market Size & Forecast by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Disease
      3. By End Use
      4. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Rest of Asia Pacific
  9. Latin America Point Of Care Infectious Disease Testing Market
    1. Market Size & Forecast by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Disease
      3. By End Use
      4. By Country
        1. Brazil
        2. Mexico
        3. Rest of Latin America
  10. Middle East & Africa Point Of Care Infectious Disease Testing Market
    1. Market Size & Forecast by Value, 2018–2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Technique
      2. By Disease
      3. By End Use
      4. By Country
        1. Saudi Arabia
        2. UAE
        3. South Africa
        4. Rest of Middle East & Africa
  11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share Analysis, 2021
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Development (Merger, Acquisition, Partnership.)
  12. Impact of Covid-19 on Global Point Of Care Infectious Disease Testing Market Industry
  13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
    1. F.Hoffmann-La Roche Ltd
    2. Thermo Fisher Scientific Inc
    3. Abbott Laboratories
    4. Quest Diagnostics Incorporated
    5. BD Company
    6. Biomerieux SA
    7. Cardinal Health Company
    8. Mesa Biotech
    9. Cepheid Company
    10. Trinity Biotech
    11. Others

 

  1. Key Strategic Recommendations

 

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

 

List Of Figures

 

Figure 1: Global Point Of Care Infectious Disease Testing Market Segmentation

Figure 2: Global Point Of Care Infectious Disease Testing Industry Value Chain Analysis

Figure 3: Global Point Of Care Infectious Disease Testing Market Size, By Value (USD Million),2018–2028

Figure 4: Global Point Of Care Infectious Disease Testing Market Share (%), By Technique, By Value, 2018–2028

Figure 5: Global Point Of Care Infectious Disease Testing Market Share (%), By Disease, By Value, 2018–2028

Figure 6: Global Point Of Care Infectious Disease Testing Market Share (%), By End Use, By Value, 2018–2028

Figure 7: Global Point Of Care Infectious Disease Testing Market Share (%), By Region, By Value, 2018–2028

Figure 8: North America Point Of Care Infectious Disease Testing Market Size, By Value (USD Million), 2018–2028

Figure 9: North America Point Of Care Infectious Disease Testing Market Share (%), By Technique, By Value, 2018–2028

Figure 10: North America Point Of Care Infectious Disease Testing Market Share (%), By Disease, By Value, 2018–2028

Figure 11: North America Point Of Care Infectious Disease Testing Market Share (%), By End Use, By Value, 2018–2028

Figure 12: North America Point Of Care Infectious Disease Testing Market Share (%), By Country, By Value, 2018–2028   

Figure 13: Europe Point Of Care Infectious Disease Testing Market Size, By Value (USD Million), 2018–2028

Figure 14: Europe Point Of Care Infectious Disease Testing Market Share (%), By Technique, By Value, 2018–2028

Figure 15: Europe Point Of Care Infectious Disease Testing Market Share (%), By Disease, By Value, 2018–2028

Figure 16: Europe Point Of Care Infectious Disease Testing Market Share (%), By End Use, By Value, 2018–2028

Figure 17: Europe Point Of Care Infectious Disease Testing Market Share (%), By Country, By Value, 2018–2028

Figure 18: Asia-Pacific Point Of Care Infectious Disease Testing Market Size, By Value (USD Million), 2018–2028

Figure 19: Asia-Pacific Point Of Care Infectious Disease Testing Market Share (%), By Technique, By Value, 2018–2028

Figure 20: Asia-Pacific Point Of Care Infectious Disease Testing Market Share (%), By Disease, By Value, 2018–2028  

Figure 21: Asia-Pacific Point Of Care Infectious Disease Testing Market Share (%), By End Use, By Value, 2018–2028

Figure 22: Asia-Pacific Point Of Care Infectious Disease Testing Market Share (%), By Country, By Value, 2018–2028

Figure 23: Latin America Point Of Care Infectious Disease Testing Market Size, By Value (USD Million), 2018–2028

Figure 24: Latin America Point Of Care Infectious Disease Testing Market Share (%), By Technique, By Value, 2018–2028

Figure 25: Latin America Point Of Care Infectious Disease Testing Market Share (%), By Disease, By Value, 2018–2028

Figure 26: Latin America Point Of Care Infectious Disease Testing Market Share (%), By End Use, By Value, 2018–2028

Figure 27: Latin America Point Of Care Infectious Disease Testing Market Share (%), By Country, By Value, 2018–2028

Figure 28: Middle East & Africa Point Of Care Infectious Disease Testing Market Size, By Value (USD Million),2018–2028

Figure 29: Middle East & Africa Point Of Care Infectious Disease Testing Market Share (%), By Technique, By Value, 2018–2028

Figure 30: Middle East & Africa Point Of Care Infectious Disease Testing Market Share (%), By Disease, By Value, 2018–2028

Figure 31: Middle East & Africa Point Of Care Infectious Disease Testing Market Share (%), By End Use, By Value, 2018–2028

Figure 32: Middle East & Africa Point Of Care Infectious Disease Testing Market Share (%), By Country, By Value, 2018–2028

Figure 33: Global Point Of Care Infectious Disease Testing Market Share Analysis, 2021

 

List Of Tables

 

Table 1: Global Point Of Care Infectious Disease Testing Market Size, By Technique, By Value (USD Million), 2018–2028

Table 2: Global Point Of Care Infectious Disease Testing Market Size, By Disease, By Value (USD Million), 2018–2028

Table 3: Global Point Of Care Infectious Disease Testing Market Size. By End Use, By Value (USD Million), 2018–2028

Table 4: Global Point Of Care Infectious Disease Testing Market Size. By Region, By Value (USD Million), 2018–2028

Table 5: North America Point Of Care Infectious Disease Testing Market Size, By Technique, By Value (USD Million), 2018–2028

Table 6: North America Point Of Care Infectious Disease Testing Market Size, By Disease, By Value (USD Million), 2018–2028

Table 7: 28 North America Point Of Care Infectious Disease Testing Market Size (USD Million), By End Use, By Value 2018–2028 

Table 8: 28 North America Point Of Care Infectious Disease Testing Market Size (USD Million), By Country, By Value 2018–2028 

Table 9: Europe Point Of Care Infectious Disease Testing Market Size, By Technique, By Value (USD Million), By Value 2018–2028

Table 10: Europe Point Of Care Infectious Disease Testing Market Size, By Disease, By Value (USD Million), By Value 2018–2028

Table 11: 40 Europe Point Of Care Infectious Disease Testing Market Size (USD Million), By End Use, By Value 2018–2028

Table 12: 40 Europe Point Of Care Infectious Disease Testing Market Size (USD Million), By Country, By Value 2018–2028

Table 13: Asia-Pacific Point Of Care Infectious Disease Testing Market Size, By Technique, By Value (USD Million), By Value 2018–2028

Table 14: Asia-Pacific Point Of Care Infectious Disease Testing Market Size (USD Million), By Disease, By Value 2018–2028

Table 15: Asia-Pacific Point Of Care Infectious Disease Testing Market Size (USD Million), By End Use, By Value 2018–2028

Table 16: Asia-Pacific Point Of Care Infectious Disease Testing Market Size (USD Million), By Country, By Value 2018–2028

Table 17: Latin America Point Of Care Infectious Disease Testing Market Size, By Technique, By Value (USD Million), By Value 2018–2028

Table 18: Latin America Point Of Care Infectious Disease Testing Market Size, By Disease, By Value (USD Million), 2018–2028

Table 19: Latin America Point Of Care Infectious Disease Testing Market Size (USD Million), By End Use, By Value 2018–2028

Table 20: Latin America Point Of Care Infectious Disease Testing Market Size (USD Million), By Country, By Value 2018–2028  

Table 21: Middle East & Africa Point Of Care Infectious Disease Testing Market Size, By Technique, By Value (USD Million), 2018–2028

Table 22: Middle East & Africa Point Of Care Infectious Disease Testing Market Size, By Disease, By Value (USD Million), 2018–2028

Table 23: Middle East & Africa Point Of Care Infectious Disease Testing Market Size (USD Million), By End Use, By Value 2018–2028

Table 24: Middle East & Africa Point Of Care Infectious Disease Testing Market Size (USD Million), By Country, By Value 2018–2028 

Table 25:  List of Key Players and Their Offerings

Table 26:  Competitive Benchmarking, by Operating Parameters

Table 27       F.Hoffmann-La Roche Ltd Company Overview

Table 28       F.Hoffmann-La Roche Financial Overview

Table 29        Thermo Fisher Scientific Inc Company Overview

Table 30        Thermo Fisher Scientific Inc Financial Overview

Table 31        Abbott Laboratories Company Overview

Table 32        Abbott Laboratories Financial Overview

Table 33        Quest Diagnostics Incorporated Company Overview

Table 34        Quest Diagnostics Incorporated Financial Overview

Table 35        BD Company Overview

Table 36        BD Financial Overview

Table 37        Biomerieux SA Company Overview

Table 38        Biomerieux SA Financial Overview

Table 39        Cardinal Health Company Overview

Table 40        Cardinal Health Company Financial Overview

Table 41        Mesa Biotech Company Overview

Table 42        Mesa Biotech Financial Overview

Table 43        Cepheid Company Overview

Table 44        Cepheid Company Financial Overview

Table 45        Trinity Biotech Company Overview

Table 46        Trinity Biotech Financial Overview

 

 

Market Segmentation

By Technique

  • Lateral Flow
  • Agglutination Assays
  • Flow-Through Test
  • Molecular Diagnostics
  • Others

By Disease

  • HIV POC
  • Clostridium difficile POC
  • HBV POC
  • Pneumonia or Streptococcus associated infections
  • Respiratory syncytial virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB and drug-resistant TB POC
  • HSV (Herpes Simplex Virus) POC
  • Others

By End Use

  • Hospitals
  • Clinics
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.